SCHEMBL14848393

SCHEMBL14848393

Cc1c2cccc1Cc1cc(C(P(=O)(O)O)P(=O)(O)O)cc(c1O)Cc1cccc(c1O)Cc1cc(C(P(=O)(O)O)P(=O)(O)O)cc(c1O)C2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRB P23467 5/20 0.67
▸ PTPN2 P17706 5/20 0.67
▸ PTPN1 P18031 5/20 0.67
▸ PTPN11 Q06124 5/20 0.67
▸ PTPRC P08575 4/20 0.67
▸ GSTA1 P08263 6/20 0.41
▸ GSTP1 P09211 6/20 0.41
▸ SRC P12931 1/20 0.41
▸ PTPN4 P29074 1/20 0.39
▸ PTPN9 P43378 1/20 0.39
▸ ACP3 P15309 1/20 0.36
▸ PGK1 P00558 4/20 0.35
▸ PGK2 P07205 4/20 0.35
▸ ING2 Q9H160 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HPN P05981 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ ALOX5 P09917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14848390 0.85 PTPRB (0.58) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL14850434 0.81 PTPRB (1.00) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL13821762 0.78 ALDH1A1 (0.42) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL14848443 0.74 PTPRB (0.49) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL18538300 0.70 ACHE (0.39) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL12856719 0.70 ACHE (0.39) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL14848403 0.69 PTPRB (0.44) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL14848402 0.69 PTPRB (0.44) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL29383145 0.67 ALDH1A1 (0.48) PTPRBPTPN2PTPN1PTPN11PTPRC
SCHEMBL29366399 0.67 ALDH1A1 (0.48) PTPRBPTPN2PTPN1PTPN11PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130090494-A1 TETRAKIS[BIS(DIHYDROXYPHOSPHORYL)METHYL]CALIX[4]ARENE OR ITS SODIUM SALT THEREOF AS FIBRIN POLYMERIZATION INHIBITORS KOMISARENKO SERHII VASYL OVYCH (UA) 2013-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090494-A1 TETRAKIS[BIS(DIHYDROXYPHOSPHORYL)METHYL]CALIX[4]ARENE OR ITS SODIUM SALT THEREOF AS FIBRIN POLYMERIZATION INHIBITORS FGB, F2, TFPI PTPRB 519/4885PTPN2 1397/4885PTPN1 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback